Biomarker-driven adjuvant targeted therapy for NSCLC-the ALCHEMIST trials

Geoffrey R. Oxnard, Colleen Watt, Dennis Wigle, Judy C. Boughey

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Biomarker-driven adjuvant targeted therapy for NSCLC-the ALCHEMIST trials'. Together they form a unique fingerprint.